Editorial: Can Glucagon Like Peptide 1 (GLP1) Agonists or Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Ameliorate Non-Alcoholic Steatohepatitis in People with or without Diabetes?

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

65

DOI https://dx.doi.org/10.2174/1570161114666160909161811	Print ISSN 1570-1611
Publisher Name Bentham Science Publisher	Online ISSN 1875-6212

Current Vascular Pharmacology